Read more about the article challenging “Good Cancer” Myth: What Patients and Clinicians Need to Know

challenging “Good Cancer” Myth: What Patients and Clinicians Need to Know

Dr. Lori Wirth, MD—Elizabeth and Michael Ruane Chair of Endocrine Oncology; Medical Director of the Massachusetts General Hospital Center for Head and Neck Cancers; and Professor of Medicine at Harvard…

Continue Readingchallenging “Good Cancer” Myth: What Patients and Clinicians Need to Know
Read more about the article A New Approach to Degenerative Disc Disease – Introducing Hydrafil

A New Approach to Degenerative Disc Disease – Introducing Hydrafil

In this MedInsights Unleashed episode, we explore an emerging treatment for chronic degenerative disc disease called Hydrafil. Our guests are Bill Niland, CEO of ReGelTec Inc. and Dr. Anthony Lowman, PhD, Professor of Biomedical Engineering and Co-Founder/Chief Medical Officer at ReGelTec.  They…

Continue ReadingA New Approach to Degenerative Disc Disease – Introducing Hydrafil